HPI Seminar Series

HPI Logo

Health Policy and Insurance Research Seminar Series


Time: Noon - 1:00 PM


Date: Seminars are usually held the 2nd and 4th Wednesday of each month with some exceptions - Please refer to the schedule for exact dates.


Location: Department of Population Medicine (DPM) Inui Conference Room A/B, Landmark Center, 401 Park Drive, Suite 401 East, Boston, MA 02215

 

Directions

 

Click here to view the background on the seminars

 

Archived Seminar Series 2017-2018

Archived Seminar Series 2016-2017

 

Want to be a part of our mailing list? Click here to Subscribe!

 

Upcoming HPI Research Seminar Schedule
All Presentations Are Held at Noon-1:00 In The Inui Conference Room

 

September 12, 2018 Seminar Title  

Lauren W.

Lauren Wisk, PhD

Assistant Professor

Instructor in Pediatrics, Harvard Medical School

 

 

An Update on Health Insurance and Access to Care for Young Adults Post Health Reform: Policy Gains and New Opportunities

 

 

 

With the passage of the Affordable Care Act (ACA) in 2010, several policies expanded access to health insurance coverage and provided protection against a high cost burden for young adults – a group that previously had the lowest rates of insurance coverage across all ages. Although large gains in coverage have been observed for this group overall as a result of the ACA, certain policies differentially affected vulnerable subgroups and continued attention to addressing the remaining gaps in coverage and access for young adults are warranted.

 

 

September 26, 2018

Seminar Title  

DRDDennis Ross-Degnan, ScD

Associate Professor

Harvard Medical School

Dept. of Population Medicine

Director of Research at Harvard Pilgrim Health Care Institute

***Please Note: This Series will begin at 1:00 PM in Conference Room 1***

Interrupted  Time Series

This session will be a tutorial aimed for new fellows, but open to all. Dr. Dennis Ross-Degnan will speak about interrupted time series basics, as well as new methods for ITS analyses, such as matching methods.

 

 

 

October 10, 2018 Seminar Title  

Mara

Mara Murray Horwitz, MD

 Research Fellow

 Dept. of Population Medicine

Variation in Primary Care Quality Measures: A Multi-Level Analysis

This study aims to understand how much of the variation in primary care quality measures may be attributed to differences between patients, providers, and clinics. Mara will discuss her collaboration with a local network of outpatient care providers, review early data analysis and results, and engage the audience in discussion about next steps ad potential clinical implications and applications.

 

 

October 17, 2018 Seminar Title  

JaiJaime Espinme Espin, PhD

Visiting Professor

Andalusian School of Public Health

 

How Europe is facing the high cost medicines challenge? 

 

This seminar will be an analysis of the different trends in Europe related to pricing and reimbursement of high cost medicines. The pricing regulations systems, the different reimbursement models, the innovative instruments and the opportunity of using biosimilars will be explained in other to compared with the current pharma policy in the US. The debate will be focus in look for commonalities and differences between the different settings.

  

October 24, 2018 Seminar Title  

Anna

Anna Sinaiko, PhD

 Harvard School of Public Health

 Dept. of Health Policy and   Management

 

Use of reference-based pricing benefit design to steer patients to low-price imaging providers

In the U.S., health care prices vary widely within local markets; and differences in price have little association with quality.  To take advantage of this price variation and decrease health care spending, insurers and employers are trying a variety of benefit designs that aim to steer patients to lower-priced providers, including reference-based pricing benefit design (RBP). We evaluate the impact of RBP for advanced imaging offered by a national commercial health plan.

        

November 14, 2018 Seminar Title  

Oreofe

Oreofe 0. Odejide, MD

 Medical Oncology

 Dana Farber Cancer Institute

 

 

Why are Patients with Blood Cancers Less Likely to Receive Quality End-of-Life Care?

Existing studies demonstrate that patients with blood cancers have high rates of intensive care near death and low rates of timely hospice enrollment – all markers of potentially suboptimal end-of-life care. During this seminar, I will examine factors (patient, physician, policy) that contribute to the current state of end-of-life care in this population.

                     

November 28, 2018 Seminar Title  

Huseyin Naci, PhDH Naci

Assistant Professor of Health Policy at the London School of Economics and Political Science

Evidence standards for approving cancer medicines in Europe

In this study, we evaluated the characteristics of clinical studies supporting the European Medicines Agency approval of new cancer medicines from 2009 to 2013. In addition, we determined the proportion of drugs with demonstrable benefit on survival or quality of life over available treatment options or placebo, both at time of approval and in the postmarking period. Finally, we investigated the magnitude of benefit of drugs showing a significant improvement on survival in the treatment of cancers. 

 

Published paper: https://www.bmj.com/content/359/bmj.j4530 

 

 

   

December 12, 2018 Seminar Title  

Kenneth Kehl

Kenneth Kehl, M.D.

 Medical Oncology

 Dana Farber Cancer Institute

Rapid innovation in the treatment of lung cancer: Real-world impact

 

 

 

The recent incorporation of precision medicine and immunotherapy into the management of advanced lung cancer has rapidly transformed treatment patterns. However, this innovation may not have been implemented equitably in the real world. I will review our efforts to understand implementation patterns to date using administrative data and to more gather evidence regarding the impact of precision medicine from the electronic health record at scale.

   

January 23, 2019 Seminar Title  

SWScott Weiner, MD, MPH

Attending Emergency Physician

Director, Brigham and Women's Comprehensive Opioid Response and Education Program

 Assistant Professor, Harvard                                                    Medical School

TBD  

 

January 30, 2019 Seminar Title  

Ed Silverman

Ed Silverman

 Pharmalot Columnist

 Senior Writer

 STAT News

TBD  

 

February 13, 2019 Seminar Title  

Jeanner Madden

Jeanne Madden, PhD

 Associate Professor

 Dept. of Pharmacy & Health

 System Sciences

 School of Pharmacy

 Northeastern University

TBD  

 

February 27, 2019 Seminar Title  

 

TBD

 

 

TBD  

 

March 13, 2019 Seminar Title  

Alessandra

Alessandra Ferrario, PhD.

 Post-doctoral Research Fellow

 Harvard Pilgrim Health Care Inst.

 Dept. of Population  Medicine

 

TBD  

 

March 27, 2019 Seminar Title  

Stacie D.

Stacie B. Dusetzina, PhD

Associate Professor, Health Policy

Ingram Associate Professor of Cancer Research, Vanderbilt University Medical Center

 

TBD  

 

April 10, 2019 Seminar Title  

YZYousuf Zafar, M.D., MHS

 Associate Professor of Medicine and Public Policy

Duke Cancer  Institute

 

TBD  

 

April 24, 2019 Seminar Title  

Amber B.Robin Yabroff

 Strategic Director

 Economic Burden of Cancer

 American Cancer Society

TBD

 

 

 

 

May 8, 2019 Seminar Title                                                                                                    

 

TBD

 

 

TBD

                                                    

 

                                                                 

 

May 22, 2019 Seminar Title  

 

TBD

 

 

 

TBD